ResearcherMedical University of BiałystokNo recent work listed
Marta Łukaszewicz-Zając
Matched on ORCID iD 0000-0002-0185-7327; OpenAlex author ID A5028270871.
Their work
- Papers
- 5 (first author 2, last author 0)
- Trials
- 0
- Grants
- 0
- Collaborators
- 3
2018: 2 papers · 2019: 2 papers · 2020: 1 paper
Papers 5
- Specific Receptors for the Chemokines CXCR2 and CXCR4 in Pancreatic Cancer. Co-author DOI 10.3390/ijms21176193↗
- Novel potential biomarkers for pancreatic cancer - A systematic review. Co-author DOI 10.1016/j.advms.2019.02.004↗
- Matrix metalloproteinase 2 (MMP-2) and its tissue inhibitor 2 (TIMP-2) in pancreatic cancer (PC). First author DOI 10.18632/oncotarget.26571↗
- The role of selected chemokines and their specific receptors in pancreatic cancer. First author DOI 10.1177/1724600817753094↗
- Serum chemokine CXCL8 as a better biomarker for diagnosis and prediction of pancreatic cancer than its specific receptor CXCR2, C-reactive protein, and classic… Co-author DOI 10.20452/pamw.4307↗
Closest collaborators
The 3 strongest of 3 ranked by shared papers, trials and grants, with recent and small-team work weighing most.
- Barbara Mroczko · 5 shared papers, 2018–2020
- Paper Novel potential biomarkers for pancreatic cancer - A systematic review. DOI 10.1016/j.advms.2019.02.004↗
- Paper The role of selected chemokines and their specific receptors in pancreatic cancer. DOI 10.1177/1724600817753094↗
- Paper Specific Receptors for the Chemokines CXCR2 and CXCR4 in Pancreatic Cancer. DOI 10.3390/ijms21176193↗
- Ala Litman-Zawadzka · 3 shared papers, 2018–2020
- Paper Novel potential biomarkers for pancreatic cancer - A systematic review. DOI 10.1016/j.advms.2019.02.004↗
- Paper Specific Receptors for the Chemokines CXCR2 and CXCR4 in Pancreatic Cancer. DOI 10.3390/ijms21176193↗
- Paper Serum chemokine CXCL8 as a better biomarker for diagnosis and prediction of pancreatic cancer than its specific recepto… DOI 10.20452/pamw.4307↗
- Maciej Szmitkowski · 1 shared paper, 2019
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.